期刊文献+

Cox-2、Topo-Ⅱ在结直肠癌组织中的表达及对奥沙利铂化疗患者预后的影响 被引量:5

Expression of Cox-2,Topo-Ⅱ in colorectal cancer tissues and its effect on prognosis of patients with colorectal cancer treated by adjuvant oxaliplatin based chemotherapy
下载PDF
导出
摘要 目的探讨结直肠癌组织中环氧合酶-2(Cox-2)与拓扑异构酶-Ⅱ(Topo-Ⅱ)的表达变化及其对奥沙利铂化疗患者预后的影响。方法随机选取69例大肠癌患者手术切除的癌组织、癌旁组织标本各69份,另取正常大肠组织标本20份,采用免疫组化SP法检测上述标本中Cox-2、Topo-Ⅱ表达。大肠癌患者术后均采用含奥沙利铂方案化疗。采用χ2检验、Log-rank分析和Cox风险模型分析Cox-2、Topo-Ⅱ表达对患者生存期的影响。结果癌组织Cox-2表达阳性率为88.4%(61/69),明显高于癌旁和正常组织(P<0.01);Topo-Ⅱ表达阳性率59.4%(41/69),与癌旁组织(56.5%)及正常组织(55.0%)表达差异无统计学意义;癌组织中Cox-2与Topo-Ⅱ表达呈正相关(r=0.254,P<0.05),Cox-2表达、Topo-Ⅱ表达是影响患者预后的独立因素。结论大肠癌组织中Cox-2、Topo-Ⅱ均呈高表达,二者可能在肿瘤MDR发生中起重要作用;其表达水平升高是影响患者术后生存期的重要因素。 Objective To investigate the expression changes of cyclooxygenase 2 ( Cox-2), topoisomerase- Ⅱ( Topo- Ⅱ ) in the colorectal cancer tissues and its effect on prognosis of patients with colorectal cancer treated by adjuvant oxalipla- tin based chemotherapy. Methods We randomly collected carcinoma tissue and adjacent tissue specimens in 69 cases of patients with colorectal cancer who underwent surgical excision, and another 20 cases of normal colon tissue specimens were selected. The expression of Cox-2 and Topo- Ⅱ in these specimens was detected by immunohistochemical SP method, and all patients received adjuvant oxaliplatin chemotherapy. The effect of Cox-2 and Topo- Ⅱ expression on the lifetime of pa- tients was analyzed with Chi-square test, Log-rank test and Cox regression model risk. Results The positive expression rate of Cox-2 was 88.40% (61/69) in the colorectal carcinoma tissues, which was significantly higher than those in the ad- jacent and normal tissues (P 〈 0.01 ) ; the positive expression rate of Tope-Ⅱ was 59.4% (41/69) in the colorectal carci- noma tissues, 56.5% in the adjacent tissues and 55% in the normal tissues. The expression of Cox-2 was positively corre- lated with Tope-Ⅱ expression in the colorectal carcinoma tissues ( r = 0. 254, P 〈 0.05 ). COX regression model risk analy- sis showed that the Cox-2 expression and Tope-Ⅱ expression were independent tactors 'affecting the prognosis of patients. Conclusions The Cox-2 and Tope-II are both highly expressed in the colorectal carcinoma, and they may play important roles in the occurrence of MDR in tumor. Its elevated expression level is an important factor of influencing lifetime of pa- tients after operation.
出处 《山东医药》 CAS 2013年第42期12-14,共3页 Shandong Medical Journal
基金 泸州市科学技术研究项目[泸市科函(2007)27号]
关键词 结直肠癌 环氧合酶-Ⅱ 拓扑异构酶-Ⅱ(Topo-Ⅱ) 生存期 colorectal carcinoma cyclooxygenase 2 topoisomerase-Ⅱ survival
  • 相关文献

参考文献12

二级参考文献62

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2陆仰东.国产奥沙利铂为主的联合化疗治疗51例晚期大肠癌疗效观察[J].中国肿瘤临床,2004,31(24):1401-1403. 被引量:5
  • 3陈立军,宋廷惠,蒋彦永,汲言山,胡美茹,沈倍奋.多药耐药基因在大肠癌中的检测及其临床意义[J].癌症,1995,14(6):407-410. 被引量:7
  • 4张惠忠,华平,李海刚,吕志强,曾韵洁,刘金耿,曾弘.非小细胞肺癌血管内皮生长因子-C和环氧合酶-2蛋白的表达及其对预后的影响[J].中华肿瘤杂志,2005,27(12):734-737. 被引量:14
  • 5[1]William SC,DuBois RN.Prostaglandins endoperoxide synthase:why two isoforms? Am J Physiol,1996,270:393-400.
  • 6[2]Bamba H,Ota S,Kato A,et al.Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells[J].Biophys Res Commun,2000,273(2):485-491.
  • 7[3]Shimizu D,Vallbohmer D,Kuramochi H,et al.Increasing cyclooxygenase-2(cox-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2[J].Int J Cancer,2006,119(4):765-770.
  • 8[4]Tuynman JB,Buskens CJ,Kemper K,et al.Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma[J].Ann Surg,2005,242(6):840-849.
  • 9[5]Miwa K,Oyama K,Fujimura T.A Cox-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats[J].Nippon Rinsho,2005,63(8):1387-1393.
  • 10[7]Zimmermann KC,Sarbia M,Weber AA,et al.Cyclooxygenase-2 expression in human esophageal carcinoma[J].Cancer Res,1999,59(1):198-204.

共引文献59

同被引文献62

  • 1张艳梅,杜金荣,付红.P-gp、GST-π、Topo-II在结直肠癌组织中的表达及其相关性[J].现代肿瘤医学,2007,15(4):544-546. 被引量:6
  • 2屠世良,叶再元,邓高里,赵仲生,董全进,郑伯安,丁丽萍,曹鸿峰.结直肠癌淋巴结转移的规律及其影响因素[J].中华胃肠外科杂志,2007,10(3):257-260. 被引量:30
  • 3郭威,宋光,吴国新,杨淑梅.GST-π、P-gp及Topo Ⅱ在大肠癌中的表达及其多药耐药的临床研究[J].齐齐哈尔医学院学报,2007,28(3):269-272. 被引量:6
  • 4Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, HOfler H, Nekarda H, Siewert JR. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 pa- tients over a 25-year time period. Ann Surg ,2008, 248:968-978 [PMID: 19092341 DOI: 10.1097/ SLA.0b013e318190eddc].
  • 5Lim YK, Law WL, Liu R, Poon JT, Fan JF, Lo OS.Impact of neoadjuvant treatment on total meso- rectal excision for ultra-low rectal cancers. World J Surg Oncol ,2010, 8:23 [PMID: 20346160 DOI: 10.1186/1477-7819-8-23].
  • 6Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto LG. Transcriptional regulators of the human multi- drug resistance 1 gene: recent views. Biochem Phar- maco12002; 64:943-948 [PMID: 12213590].
  • 7Chang HC, Huang SC, Chert JS, Tang R, Changclen CR, Chiang JM, Yeh CY, Hsieh PS, Tsai WS, Hung HY, You JF. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single- institute experience in 943 patients and literature review. Ann Surg Oncol ,2012, 19:2477-2484 [PMID: 22396007 DOI: 10.1245/s10434-012-2303-9].
  • 8Tsai HL, Cheng KI, Lu CY, Kuo CH, Ma CJ, Wu JY, Chai CY, Hsieh JS, Wang JY. Prognostic signifi- cance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergo- ing radical resection. J Surg Oncol ,2008, 97:383-387 [PMID: 18163435 DOI: 10.1002/jso.20942].
  • 9Nagy VM. Updating the management of rectal can- cer. J Gastrointestin Liver Dis ,2008, 17:69-74 [PMID: 18392247].
  • 10Thorn CC, Woodcock NP, Scott N, Verbeke C, Scott SB, Ambrose NS. What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis ,2004, 6:356-361 [PMID: 15335370].

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部